Pamela DeLuca
Italian Medicines Agency(IT)
Publications by Year
Research Areas
Fatty Acid Research and Health, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Natural product bioactivities and synthesis, Cholesterol and Lipid Metabolism
Most-Cited Works
- → Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies(2005)398 cited
- → Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation(1997)77 cited
- → Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors(2008)71 cited
- Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo.(1999)
- → MARINE AND BOTANICAL LIPIDS AS IMMUNOMODULATORY AND THERAPEUTIC AGENTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS(1995)47 cited
- → Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency(2016)40 cited
- → A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies(2004)32 cited
- → A phase 1 trial of XK469: Toxicity profile of a selective topoisomerase IIβ inhibitor(2006)28 cited
- → Botanical lipids: Effects on inflammation, immune responses, and rheumatoid arthritis(1995)24 cited
- → AZD2171 in combination with various anticancer regimens: Follow-up results of a phase I multi-cohort study(2007)8 cited